“mirna-therapeutics” Archives

in
Entry Author Date Location
Five Questions For … Austin Biotech Entrepreneur Paul Lammers 09/29/17 Texas
Houston Biotech Oncolix Announces Reverse Merger, Goes Public 08/07/17 Texas
Acer Therapeutics Announces Reverse Merger With Houston’s Opexa 07/05/17 Texas
Synlogic and Its Modified Bacteria Take Over Dying Company, Go Public 05/16/17 Boston
CPRIT Marks Midpoint in Texas Agency’s 10-Year Cancer-Fighting Mandate 05/18/16 Texas
Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations 10/29/15 San Francisco
Gene Therapy Startup Dimension Cuts Price But Bags $72M in IPO 10/21/15 Boston
Voyager Charts an IPO Course Amid Choppy Biotech Waters 10/11/15 Boston
Bio Slump Hits IPOs as Edge, Mirna Cut Prices, Upsize to Close Deals 10/01/15 New York
Mirna Therapeutics Secures $44,100,000 New Financing 09/30/15 Texas
Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO 09/28/15 San Francisco
Verastem Sinks as Mesothelioma Study Halted For Futility 09/28/15 Boston
Texas Roundup: Favor, UT-San Antonio, Yan Engines, Health Wildcatters 08/28/15 Texas
Austin Cancer Drugs Developer Mirna Therapeutics Files for an IPO 08/24/15 Texas
Austin Biotech Mirna Therapeutics Nabs Nearly $42M in Series D Funding 04/30/15 Texas
Mirna Therapeutics Lands $41,800,000 Series D Financing Round 04/30/15 Texas
New Funding, Commercialization Officer at Texas Cancer Agency 05/22/14 Texas
Mirna Therapeutics Taking on Cancer With Help of Tiny RNAs 07/09/13 Texas
Mirna Therapeutics Secures $34,500,000 Series C Funding Round 10/24/12 Texas
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs 12/12/11 Seattle
Mirna Therapeutics Secures $1,500,000 New Financing 08/23/11 Texas
Mirna Therapeutics Lands $25,000,000 New Financing Round 09/30/10 Texas
Mirina Vs. Marina: The Looming Court Battle Over Biotech Company Names 08/16/10 Seattle
Accelerator’s MicroRNA Play, Mirina, Forges Ahead With One More Year of Cash 04/26/10 Seattle
Page 1 of 1